Peter Kash

Peter Kash

Direktor/Vorstandsmitglied bei HEAE CAPI

Vermögen: 217 924 $ am 31.10.2026

64 Jahre
Health Technology
Finance
Consumer Services

Profil

Peter Morgan Kash was the founder of Arno Therapeutics, Inc. founded in 2000, where the title held was Director in 2011.
Dr. Kash was the founder of Targimmune Therapeutics AG founded in 2015, where the title held was Vice Chairman from 2015 to 2025.
Dr. Kash is also the founder of PolaRx Biopharmaceuticals,Andorra International, Inc.,Keryx Biopharmaceuticals, Inc...- Current jobs include Chairman at Cellergy Therapeutics Ltd. starting 2025; Director at Kirax Corp., Danube Pharmaceuticals, Inc., Cancer Schmancer Foundation, Fran Dreschers Organization, and Keren Or, Inc.; Managing Director at FFD, Inc. since 2017; Independent Director at Healthcare Capital Corp.
(Delaware) since 2021 and at Xtend AI Robotics, Inc. starting 2026; President at Two River Group Management LLC.
Former jobs included Vice Chairman at Javelin Pharmaceuticals, Inc., Velcera Pharmaceuticals, Inc., and INVO Fertility, Inc.; Chairman & President at Riverbank Capital Securities, Inc.; Director at Paramount BioCapital Asset Management, Inc., Intercept Pharmaceuticals, Inc., Arno Therapeutics, Inc., DarioHealth Corp.
(2014-2015), ID Vaccine Corp., Nile Therapeutics, Inc., and Capricor Therapeutics, Inc.; Senior Managing Director at Paramount BioCapital, Inc. from 1992 to 2004; Non-Executive Director at Firebrick Pharma Ltd. from 2020 to 2021; Partner at Two River Group Holdings LLC; Adjunct Professor at the University of Pennsylvania in 2000; General Partner at Orion Biomedical Fund LP; Associate Professor-Marketing at Polytechnic University in 1992.
Education includes a doctorate from Yeshiva University, an undergraduate degree from State University of New York at Binghamton, and an MBA from Lubin School of Business.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
0,06 %
15.10.2026 141.509 ( 0,06 % ) 217 924 $ 31.10.2026

Aktive Positionen von Peter Kash

UnternehmenPositionBeginn
HEAE CAPI Direktor/Vorstandsmitglied 20.01.2021
Two River Group Management LLC
Präsident 23.06.2010
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 27.11.2009
Fran Dreschers Organization
Direktor/Vorstandsmitglied 27.11.2009
Direktor/Vorstandsmitglied 27.11.2009
Direktor/Vorstandsmitglied 23.03.2011
Corporate Officer/Principal 01.09.2017

Ehemalige bekannte Positionen von Peter Kash

UnternehmenPositionEnde
Gründer 01.01.2025
░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Peter Kash im Detail an

Ausbildung von Peter Kash

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

83

Beziehungen ersten Grades

32

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen32

Finance

Health Technology

Finance

Finance

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Orion Biomedical Fund LP

Commercial Services

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Two River Group Management LLC

Fran Dreschers Organization

Miscellaneous

Health Technology

Health Technology

Health Technology

Technology Services

Consumer Services

Finance

  1. Börse
  2. Insider
  3. Peter Kash